Publications by authors named "Mark Estabrook"

Claim this Profile
E
Erratum for Estabrook et al., "Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Collected as Part of a Global Surveillance Study, 2018 to 2019".
Mark Estabrook, Astrid Muyldermans, Daniel Sahm, Denis Pierard, Gregory Stone

Antimicrob Agents Chemother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility profile and β-lactamase content of global isolates resistant to ceftolozane/tazobactam and/or imipenem/relebactam-SMART 2016-21.
James A Karlowsky, Sibylle H Lob, Mark A Estabrook, Fakhar Siddiqui, C Andrew DeRyke

JAC Antimicrob Resist· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Collected as Part of a Global Surveillance Study, 2018 to 2019.
Mark Estabrook, Astrid Muyldermans, Daniel Sahm, Denis Pierard, Gregory Stone

Antimicrob Agents Chemother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa - Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020.
Sibylle H Lob, Mark A Estabrook, C Andrew DeRyke, Irina Alekseeva, Fakhar Siddiqui

Int J Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012-2017.
Mark Estabrook, Krystyna M Kazmierczak, Mark Wise, Francis F Arhin, Gregory G Stone

J Glob Antimicrob Resist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program.
Mark G Wise, Mark A Estabrook, Daniel F Sahm, Gregory G Stone, Krystyna M Kazmierczak

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.
Henry Li, Mark Estabrook, George A Jacoby, Wright W Nichols, Raymond T Testa

Antimicrob Agents Chemother· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases.
Mark Estabrook, Brianne Bussell, Susan L Clugston, Karen Bush

J Clin Microbiol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
Darren Haskett, Jefferson J Doyle, Connie Gard, Hwudaurw Chen, Corbie Ball, Mark A Estabrook

Cell Tissue Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of mice with a conditional allele for the transforming growth factor beta3 gene.
Thomas Doetschman, Teodora Georgieva, Hongqi Li, Thomas D Reed, Christina Grisham, Mark A Estabrook

Genesis· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis